Variant report
Variant | nsv598329 |
---|---|
Chromosome Location | chr5:61574836-61576265 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:61570852..61575397-chr5:61600002..61603728,9 | K562 | blood: | |
2 | chr5:61573722..61577065-chr5:61577950..61581609,5 | K562 | blood: | |
3 | chr5:61560442..61563605-chr5:61575064..61578930,3 | K562 | blood: | |
4 | chr5:61574738..61576264-chr5:61698125..61699775,2 | K562 | blood: | |
5 | chr5:61568618..61571084-chr5:61573101..61574954,2 | K562 | blood: | |
6 | chr5:61570852..61575074-chr5:61600002..61604457,10 | K562 | blood: | |
7 | chr5:61570576..61576152-chr5:61577980..61582631,7 | K562 | blood: | |
8 | chr5:61574146..61576082-chr5:61601811..61603666,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000068796 | chromatin interactions |
ENSG00000086189 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10471543 | chr5:61574836-61574837 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs549804528 | chr5:61574838-61574839 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs149001860 | chr5:61574846-61574847 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs138571574 | chr5:61574849-61574850 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs111844719 | chr5:61574854-61574855 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs577081988 | chr5:61574855-61574856 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs546090771 | chr5:61574859-61574860 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs565307947 | chr5:61574862-61574863 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs147965793 | chr5:61574877-61574878 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs4016557 | chr5:61574880-61574881 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs191580579 | chr5:61574892-61574893 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs182700819 | chr5:61574965-61574966 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs187921146 | chr5:61574974-61574975 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs141404701 | chr5:61574978-61574979 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs535100018 | chr5:61574979-61574980 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs554804331 | chr5:61574985-61574986 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs574771525 | chr5:61575018-61575019 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs569255982 | chr5:61575020-61575021 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs192219080 | chr5:61575033-61575034 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs556947899 | chr5:61575034-61575035 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs575900402 | chr5:61575046-61575047 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs372015916 | chr5:61575062-61575063 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs544926734 | chr5:61575075-61575076 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs536954160 | chr5:61575084-61575085 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs565069038 | chr5:61575085-61575086 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs112535908 | chr5:61575193-61575194 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs145127327 | chr5:61575198-61575199 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs570395590 | chr5:61575242-61575243 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs529821847 | chr5:61575254-61575255 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs4037270 | chr5:61575262-61575263 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs569690744 | chr5:61575264-61575265 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs3857258 | chr5:61575268-61575269 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs368583535 | chr5:61575286-61575287 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs70977896 | chr5:61575328-61575329 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs79447046 | chr5:61575329-61575330 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs58554268 | chr5:61575333-61575334 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs565617795 | chr5:61575334-61575335 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs150417265 | chr5:61575411-61575412 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs113629485 | chr5:61575412-61575413 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs3846468 | chr5:61575415-61575416 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs117025902 | chr5:61575439-61575440 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs373752269 | chr5:61575447-61575448 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs56128043 | chr5:61575517-61575518 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs537167568 | chr5:61575519-61575520 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs138154293 | chr5:61575547-61575548 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs576855523 | chr5:61575568-61575569 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs115213594 | chr5:61575571-61575572 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs558621418 | chr5:61575593-61575594 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs572203099 | chr5:61575613-61575614 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs540827358 | chr5:61575657-61575658 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:61571600-61577400 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr5:61573200-61575000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr5:61573200-61576400 | Weak transcription | Fetal Intestine Large | intestine |
4 | chr5:61573400-61575000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr5:61573600-61575400 | Weak transcription | GM12878-XiMat | blood |
6 | chr5:61573600-61575800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr5:61573600-61575800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr5:61573600-61576000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr5:61573800-61575600 | Weak transcription | NHEK | skin |
10 | chr5:61573800-61575800 | Weak transcription | HMEC | breast |
11 | chr5:61573800-61577800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
12 | chr5:61574800-61575000 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr5:61574800-61577400 | Weak transcription | K562 | blood |
14 | chr5:61575000-61576800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr5:61575000-61577000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr5:61575000-61577800 | Weak transcription | Primary hematopoietic stem cells | blood |
17 | chr5:61575600-61578000 | Enhancers | NHEK | skin |
18 | chr5:61575800-61576000 | Enhancers | GM12878-XiMat | blood |
19 | chr5:61575800-61576200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
20 | chr5:61575800-61576400 | Enhancers | HepG2 | liver |
21 | chr5:61575800-61578200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
22 | chr5:61575800-61579000 | Enhancers | HMEC | breast |
23 | chr5:61575800-61580000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
24 | chr5:61576000-61577600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |